Related Experiment Video
Updated: Jul 29, 2025
Hand-held Clinical Photoacoustic Imaging System for Real-time Non-invasive Small Animal Imaging
Published on: October 16, 2017
Personalized Cancer Therapeutics Using Photoacoustic Imaging-Guided Sonodynamic Therapy
Abstract:
Sonodynamic therapy (SDT) is a promising approach for cancer treatment that uses sonosensitizers (SNSs) to generate reactive oxygen species (ROS) in the presence of ultrasound (US). However, SDT is oxygen-dependent and requires an imaging tool to monitor the tumor microenvironment and guide treatment. Photoacoustic imaging (PAI) is a noninvasive and powerful imaging tool that offers high spatial resolution and deep tissue penetration. PAI can quantitatively assess tumor oxygen saturation (sO2) and guide SDT by monitoring time-dependent sO2 changes in the tumor microenvironment. Here, we discuss recent advances in PAI-guided SDT for cancer therapy. We discuss various exogenous contrast agents and nanomaterial-based SNSs developed for PAI-guided SDT. Additionally, combining SDT with other therapies, including photothermal (PTT) therapy, can enhance its therapeutic effect. However, the application of nanomaterial-based contrast agents in PAI-guided SDT for cancer therapy remains challenging due to the lack of simple designs, the need for extensive pharmacokinetic studies, and high production costs. Integrated efforts from researchers, clinicians, and industry consortia are necessary for the successful clinical translation of these agents and SDT for personalized cancer therapy. PAI-guided SDT shows the potential to revolutionize cancer therapy and improve patient outcomes, but further research is necessary to realize its full potential.
Insights
Photoacoustic imaging (PAI) guides sonodynamic therapy (SDT) for cancer by monitoring oxygen levels. This approach enhances treatment effectiveness but faces challenges in clinical translation.
Area of Science:
- Biomedical Engineering
- Oncology
- Medical Imaging
Background:
- Sonodynamic therapy (SDT) utilizes sonosensitizers and ultrasound to generate reactive oxygen species (ROS) for cancer treatment.
- SDT's efficacy is limited by oxygen dependence and the need for precise tumor microenvironment monitoring.
- Photoacoustic imaging (PAI) offers noninvasive visualization with high resolution and deep tissue penetration, enabling quantitative assessment of tumor oxygen saturation (sO2).
Purpose of the Study:
- To review recent advancements in photoacoustic imaging-guided sonodynamic therapy for cancer treatment.
- To discuss the development and application of contrast agents and nanomaterial-based sonosensitizers for PAI-guided SDT.
- To explore the synergistic potential of combining PAI-guided SDT with other therapies like photothermal therapy (PTT).
Main Methods:
- Review of current literature on PAI-guided SDT in preclinical and clinical settings.
- Analysis of various exogenous contrast agents and nanomaterial-based sonosensitizers designed for PAI-guided SDT.
- Discussion of strategies for integrating PAI with SDT and other therapeutic modalities.
Main Results:
- PAI can quantitatively monitor tumor sO2, providing crucial guidance for SDT delivery and efficacy assessment.
- Development of novel contrast agents and nanomaterial-based sonosensitizers tailored for PAI-guided SDT.
- Combination therapies, such as PAI-guided SDT with PTT, show enhanced anti-cancer effects.
Conclusions:
- PAI-guided SDT represents a promising strategy for personalized cancer therapy by enabling real-time monitoring and targeted treatment.
- Challenges remain in the clinical translation of nanomaterial-based agents, including design simplicity, pharmacokinetic profiling, and cost-effectiveness.
- Collaborative efforts among researchers, clinicians, and industry are essential to overcome these hurdles and realize the full potential of PAI-guided SDT.
More Related Videos
09:07Sonodynamic Therapy for the Treatment of Glioblastoma Multiforme in a Mouse Model Using a Portable Benchtop Focused Ultrasound System
Published on: February 10, 2023
09:56Universal Hand-held Three-dimensional Optoacoustic Imaging Probe for Deep Tissue Human Angiography and Functional Preclinical Studies in Real Time
Published on: November 4, 2014
